Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CIR Director Gill Steps Down, Leaving Legacy Of Improved Transparency

Apr 14 2017

• By Lauren Nardella

Related Content

CIR Model For Ingredient Assessment Piques China's Interest

Sep 29 2015

Industry, FDA Discuss Making CIR Program ‘More Robust’

Mar 19 2015

Cosmetic Ingredient Use Under Feinstein Bill; Where Does CIR Come In?

Apr 22 2015

CIR Looks To Boost Program’s “Credibility And Visibility” Worldwide

Sep 29 2014

FDA Questions Constitutionality Of Proposed CIR Bridge, A Blow To CMA Bill

Nov 04 2016

House Cosmetics Bill Reintroduced; ICMAD Optimistic In New Political Climate

Jan 13 2017

WVE Letter Prompts CIR Panel To Rethink Aerosol Cosmetics, Inhalation

Apr 14 2017

PCPC Hatching Proposal For CIR Role In FDA Ingredient Review

Mar 08 2017

CIR Panel Sets Plan For Tackling Ingredients’ Inhalation Toxicity Data

Oct 17 2011

Gill To Take CIR Director Role With Andersen’s Exit

Apr 01 2013

Additional Topics

United States Cosmetics Ingredients Consumer

More from Ingredients & Safety

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window